Company Profile
Agios Pharmaceuticals, Inc. Stock Price, News & Analysis
- Ticker:
- AGIO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Agios Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
35.59 USD (+1.40%)
Close
Last updated: June 23, 2026 at 00:00
2.12B USD
Market cap
Why the stock is moving
AGIO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Agios Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Agios Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Agios Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Agios Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Agios Pharmaceuticals, Inc. (AGIO)?
Agios Pharmaceuticals, Inc. (AGIO) most recently closed at 35.59 USD, a +1.40% move versus the previous session.
What is the market cap of Agios Pharmaceuticals, Inc. (AGIO)?
Agios Pharmaceuticals, Inc. currently has a market capitalization of 2.12B USD on BioPharmSignal.
What does Agios Pharmaceuticals, Inc. do?
Agios Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is AGIO stock listed?
Agios Pharmaceuticals, Inc. (AGIO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Agios Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Agios?
Agios Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Agios Pharmaceuticals, Inc. targeting with Agios?
Agios Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceuticals?
Agios Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.